ReviewJournal of cardiovascular translational research2016
Why QRS Duration Should Be Replaced by Better Measures of Electrical Activation to Improve Patient Selection for Cardiac Resynchronization Therapy.
Review in Journal of cardiovascular translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Soluble ST2 and Risk of Arrhythmias, Heart Failure, or Death in Patients with Mildly Symptomatic Heart Failure: Results from MADIT-CRT.Journal of cardiovascular translational research · 2016Trial
- Septal-to-basal ventricular peak activation time determined by vectorcardiography as a potential new pre-screening parameter for preclinical dilated cardiomyopathy in Doberman Pinschers.Frontiers in veterinary science · 2025Article
- Time-related factors predicting a positive response to cardiac resynchronisation therapy in patients with heart failure.Scientific reports · 2023Article
- Article
- Does mechanical dyssynchrony in addition to QRS area ensure sustained response to cardiac resynchronization therapy?European heart journal. Cardiovascular Imaging · 2022Article
- Vectorcardiographic QRS area as a predictor of response to cardiac resynchronization therapy.Journal of geriatric cardiology : JGC · 2022Article
- Electrocardiographic markers of cardiac resynchronization therapy response: delayed time to intrinsicoid deflection onset in lateral leads.Journal of geriatric cardiology : JGC · 2022Article
- Determinants of the time-to-peak left ventricular dP/dt (Td) and QRS duration with different fusion strategies in cardiac resynchronization therapy.Frontiers in cardiovascular medicine · 2022Article
- Acute Hemodynamic Effects of Simultaneous and Sequential Multi-Point Pacing in Heart Failure Patients With an Expected Higher Rate of Sub-response to Cardiac Resynchronization Therapy: Results of Multicenter SYNSEQ Study.Frontiers in cardiovascular medicine · 2022Article
- Determinants of LV dP/dtOpen heart · 2021Observational
- A Comparison of the Electrophysiological and Anatomic Characteristics of Pacing Different Branches of the Left Bundle Conduction System.Frontiers in cardiovascular medicine · 2021Article
- Non-invasive cardiac mapping for non-response in cardiac resynchronization therapy.Annals of medicine · 2019Review
- The relationship between ECG predictors of cardiac resynchronization therapy benefit.PloS one · 2019Article
- Novel approach to discriminate left bundle branch block from nonspecific intraventricular conduction delay using pacing-induced functional left bundle branch block.Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2018Article
- Early prediction of cardiac resynchronization therapy response by non-invasive electrocardiogram markers.Medical & biological engineering & computing · 2018Article
- QRS Complex Detection and Measurement Algorithms for Multichannel ECGs in Cardiac Resynchronization Therapy Patients.IEEE journal of translational engineering in health and medicine · 2018Article
- Comparison of three-dimensional echocardiography and speckle tracking echocardiography in quantification and mapping of intraventricular mechanical dyssynchrony.Indian heart journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiac resynchronization therapy (CRT) is a well-known treatment modality for patients with a reduced left ventricular ejection fraction accompanied by a ventricular conduction delay. However, a large proportion of patients does not benefit from this therapy. Better patient selection may importantly reduce the number of non-responders. Here, we review the strengths and weaknesses of the electrocardiogram (ECG) markers currently being used in guidelines for patient selection, e.g., QRS duration and morphology. We shed light on the current knowledge on the underlying electrical substrate and the mechanism of action of CRT. Finally, we discuss potentially better ECG-based biomarkers for CRT candidate selection, of which the vectorcardiogram may have high potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.